Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-130312)

Filing Details

Accession Number:: 0001209191-16-130312
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-06-30 18:58:56
Reporting Period:: 2016-06-28

Filing Date:: 2016-06-30
Accepted Time:: 2016-06-30 18:58:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326732	Xencor Inc	XNCR	Pharmaceutical Preparations (2834)	201622502

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591213	A Paul Foster	C/O Xencor, Inc. 111 West Lemon Avenue Monrovia CA 91016	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-06-28	1,183	$17.01	2,419	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted November 23, 2015.